Treatment of a case of COVID-19 by intravenous immunoglobulin

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a positive-sense single-stranded RNA virus. As of today, no specific treatment has been found COVID-19. İntravenous immunoglobulin (IVIG) is a widely used therapy to prevent life-threatening infections in patients with primary and secon...

Full description

Bibliographic Details
Main Authors:	Mustafa Çolak, Serdar Kalemci, Aydın Sarıhan
Format:	Article
Language:	English
Published:	Elsevier 2021-03-01
Series:	Journal of Global Antimicrobial Resistance
Subjects:	COVID-19 Coronavirus intravenous immunoglobulin
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213716520303179

id	doaj-986faa059c4f43779aa59e77c3964702
record_format	Article
spelling	doaj-986faa059c4f43779aa59e77c39647022021-06-09T05:58:10ZengElsevierJournal of Global Antimicrobial Resistance2213-71652021-03-0124106107Treatment of a case of COVID-19 by intravenous immunoglobulinMustafa Çolak0Serdar Kalemci1Aydın Sarıhan2Department of Chest Diseases, Isparta City Hospital, Isparta, TurkeyDepartment of Chest Diseases, Medical Park Gebze Hospital, Kocaeli, TurkeyDepartment of Emergency Medicine, Manisa City Hospital, Manisa, Turkey; Corresponding author.Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a positive-sense single-stranded RNA virus. As of today, no specific treatment has been found COVID-19. İntravenous immunoglobulin (IVIG) is a widely used therapy to prevent life-threatening infections in patients with primary and secondary immune deficiencies and autoimmune/inflammatory conditions. IVIG administration could be beneficial in the treatment of patients with severe COVID-19. In this respect, this presentation aimed to report a case of COVID-19 treated with IVIG.http://www.sciencedirect.com/science/article/pii/S2213716520303179COVID-19Coronavirusintravenous immunoglobulin
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Mustafa Çolak Serdar Kalemci Aydın Sarıhan
spellingShingle	Mustafa Çolak Serdar Kalemci Aydın Sarıhan Treatment of a case of COVID-19 by intravenous immunoglobulin Journal of Global Antimicrobial Resistance COVID-19 Coronavirus intravenous immunoglobulin
author_facet	Mustafa Çolak Serdar Kalemci Aydın Sarıhan
author_sort	Mustafa Çolak
title	Treatment of a case of COVID-19 by intravenous immunoglobulin
title_short	Treatment of a case of COVID-19 by intravenous immunoglobulin
title_full	Treatment of a case of COVID-19 by intravenous immunoglobulin
title_fullStr	Treatment of a case of COVID-19 by intravenous immunoglobulin
title_full_unstemmed	Treatment of a case of COVID-19 by intravenous immunoglobulin
title_sort	treatment of a case of covid-19 by intravenous immunoglobulin
publisher	Elsevier
series	Journal of Global Antimicrobial Resistance
issn	2213-7165
publishDate	2021-03-01
description	Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a positive-sense single-stranded RNA virus. As of today, no specific treatment has been found COVID-19. İntravenous immunoglobulin (IVIG) is a widely used therapy to prevent life-threatening infections in patients with primary and secondary immune deficiencies and autoimmune/inflammatory conditions. IVIG administration could be beneficial in the treatment of patients with severe COVID-19. In this respect, this presentation aimed to report a case of COVID-19 treated with IVIG.
topic	COVID-19 Coronavirus intravenous immunoglobulin
url	http://www.sciencedirect.com/science/article/pii/S2213716520303179
work_keys_str_mv	AT mustafacolak treatmentofacaseofcovid19byintravenousimmunoglobulin AT serdarkalemci treatmentofacaseofcovid19byintravenousimmunoglobulin AT aydınsarıhan treatmentofacaseofcovid19byintravenousimmunoglobulin
_version_	1721388376616075264

Treatment of a case of COVID-19 by intravenous immunoglobulin

Similar Items